MDS Pharma   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: King of Prussia PA United States (1933)
Status: Acquired by INC Research (2009)

Organization Overview

First Clinical Trial
2002
NCT01133444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MDS Pharma Services | MDS Pharma Services, 621 Rose Street, Lincoln, NE 68502, USA | MDS Pharma Services (Celerion) | MDS Pharma Services Germany GmbH, Hamburg | MDS Pharma Services Inc | MDS Pharma Services, Inc | MDS Pharma Services Switzerland AG | MDS Pharma Services (US)

Active Ingredients

Drugs in Phase 4 Trials (3)

atorvastatin (lipitor) (1 trial)

morphine (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 3 Trials (5)

acetaminophen (tylenol) (1 trial)

fluticasone (cutivate) (1 trial)

formoterol (foradil) (1 trial)

fospropofol (lusedra) (2 trials)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (9)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (1 trial)

ethanol (1 trial)

foravirumab (1 trial)

inactivated influenza vaccine (1 trial)

istaroxime (1 trial)

phentermine (wyamine) (1 trial)

rabies immune globulin (human) (HyperRAB) (1 trial)

trastuzumab (herceptin) (1 trial)

Drugs in Phase 1 Trials (46)

Key: MDS Pharma (43) Acquired (3)

acetylsalicylic acid (aspirin) (1 trial)

amlodipine (norvasc) (4 trials)

anafranil clomipramine hydrochloride (1 trial)

avanafil (stendra) (1 trial)

azithromycin (zithromax) (2 trials)

benazepril (lotensin) (2 trials)

bilastine (2 trials)

botulinum antitoxin heptavalent (a b c d e f g) - (equine) (1 trial)

bromocriptine (parlodel) (2 trials)

buspirone (buspar) (2 trials)

cefprozil (cefzil) (4 trials)

cefuroxime (zinacef) (4 trials)

cilostazol (pletal) (1 trial)

clomipramine (anafranil) (2 trials)

conjugated equine estrogens (Premarin) (1 trial)

cs-8080 (1 trial)

deoxycholic acid (kybella) (1 trial)

desmopressin (ddavp) (1 trial)

doxazosin (cardura) (1 trial)

ebselen (1 trial)

esomeprazole (nexium) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

finasteride (Proscar) (2 trials)

fluconazole (diflucan) (2 trials)

fluvastatin (lescol) (1 trial)

ilaprazole (noltec) (1 trial)

imipramine (tofranil) (1 trial)

ketoconazole (nizoral) (1 trial)

levetiracetam (keppra) (5 trials)

medroxyprogesterone (provera) (1 trial)

midazolam (versed) (2 trials)

mifepristone (mifeprex) (1 trial)

moxifloxacin (avelox) (1 trial)

norethindrone (1 trial)

np-015 (1 trial)

omeprazole (prilosec) (1 trial)

pantoprazole (protonix) (2 trials)

pretomanid (3 trials)

quinapril (accupril) (1 trial)

quinine (qualaquin) (2 trials)

risperidone (risperdal) (2 trials)

tamsulosin (flomax) (1 trial)

testosterone (delatestryl) (1 trial)

tramadol (Ultram) (1 trial)

venlafaxine (effexor) (1 trial)

verapamil (calan) (1 trial)

Drugs in Other Trials (6)

90-yttrium (1 trial)

clarithromycin (biaxin) (2 trials)

cyanocobalamin (berocca) (1 trial)

granisetron (kytril) (2 trials)

mercaptopurine (purinethol) (1 trial)

oxcarbazepine (trileptal) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anthrax (Phase 1)

Arteriosclerosis (Phase 4)

Asthma (Phase 3)

Bipolar Disorder (Phase 4)

Breast Neoplasms (Phase 2)

Colonic Polyps (Phase 3)

Coronary Artery Disease (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Erectile Dysfunction (Phase 1)

Hearing Loss (Phase 1)

Heart Failure (Phase 2)

Hypercholesterolemia (Phase 4)

Influenza, Human (Phase 2)

Malnutrition (Phase 1)

Myocardial Ischemia (Phase 4)

Overweight (Phase 2)

Pain, Postoperative (Phase 3)

Rabies (Phase 2)

Seizures (Phase 1)

Sexual Dysfunctions, Psychological (Phase 1)

Tuberculosis (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 75
  • # of Trial APIs: 69